Caroline Weipert
Impact in
-
- Cancer Genomics and Diagnostics
-
- Acute Myeloid Leukemia Research
Papers in
-
- Cancer Genomics and Diagnostics 26
-
- Advanced Breast Cancer Therapies 9
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Victoria M. Raymond (5 shared papers)Sabah Kadri (2 shared papers)Zejuan Li (2 shared papers)Razelle Kurzrock (4 shared papers)Mark W. Lingen (1 shared paper)Lucy A. Godley (1 shared paper)Michael W. Drazer (1 shared paper)Gordana Raca (1 shared paper)
- Journals
- Journal of Clinical Oncology (16 papers)Clinical Cancer Research (4 papers)JCO Precision Oncology (3 papers)Cancer Research (3 papers)Clinical Lung Cancer (2 papers)
- Partner nations
- United StatesJapanMexico
In The Last Decade
Caroline Weipert
32 papers receiving 295 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 124
- Hematology 58
- Oncology 101
- Genetics 35
- Pulmonary and Respiratory Medicine 107
Countries citing papers authored by Caroline Weipert
This map shows the geographic impact of Caroline Weipert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Weipert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Weipert more than expected).
Fields of papers citing papers by Caroline Weipert
This network shows the impact of papers produced by Caroline Weipert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Weipert. The network helps show where Caroline Weipert may publish in the future.
Co-authors
The 25 scholars most cited alongside Caroline Weipert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 65 | |
| 2 | 2017 | 23 | |
| 3 | 2021 | 18 | |
| 4 | 2019 | 18 | |
| 5 | 2018 | 16 | |
| 6 | 2016 | 16 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 14 | |
| 9 | 2018 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2024 | 6 | |
| 18 | 2024 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 2 |
About Caroline Weipert
Caroline Weipert is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Genetics, having authored 40 papers that have together received 296 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (26 papers), Advanced Breast Cancer Therapies (9 papers), Genetic factors in colorectal cancer (8 papers), BRCA gene mutations in cancer (6 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers), Cancer Treatment and Pharmacology (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Cancer Research (124 citations), Hematology (58 citations), Oncology (101 citations), Genetics (35 citations) and Pulmonary and Respiratory Medicine (107 citations). Caroline Weipert has collaborated with scholars based in United States, Japan and Mexico. Frequent co-authors include Victoria M. Raymond, Sabah Kadri, Zejuan Li, Razelle Kurzrock, Mark W. Lingen, Lucy A. Godley, Michael W. Drazer, Gordana Raca, Christopher K. Daugherty and David R. Gandara. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, JCO Precision Oncology, Cancer Research and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.